Thymosin β4 is a 43 amino acid peptide. It is the most abundant member of the β-thymosin family in mammalian tissue and is regarded as the main intracellular G-actin sequestering peptide. Thymosin β4 has multiple biological activities including prevention of apoptosis, reduction of inflammation, and promotion of angiogenesis and cell migration. Due to its role in protection and regeneration of injured or damaged tissue thymosin β4 has received considerable interest as a potential therapeutic agent. Most recently, Xiong et al. demonstrated that delayed administration of thym…
Read More
Related Links:
Bachem – Your Partner for Bioactive Peptides
Bachem Divests Stake in Polyphor
Bachem to Supply ISA Pharmaceuticals with Finished Dosage Forms of Immunotherapeutic HPV-SLP for Phase III Clinical Trials
Further information:
Related posts:
- Bachem – Your Reliable Manufacturer of Custom Peptides
- 29 New Products Now Available from Bachem
- RepRegen™ Reports Potential Advance In The Repair And Regeneration Of Hard-Tissue, Such As Bone
- Æterna Zentaris Partner, Keryx Biopharmaceuticals, to Present Poster Highlighting Clinical Activity of Perifosine (KRX-0401) at
- A CD36 synthetic peptide inhibits silica-induced lung fibrosis in the mice

Posted in